Pentalfluoroalkanesulfinyl naphthalenes and related estrogen receptor modulators

Pentalfluoroalkanesulfinyl naphthalenes and related estrogen receptor modulators

14 1 14 214 21 22 322 The present invention provides a compound of the formula (I) wherein R is -H, or -C-Calkyl; Ris -H, -OH, -O(C-Calkyl), -SO(C-Calkyl), or halo; X is -O-, -CH-, or -C(O)-; Xis -O- or -NR-; Ris -H or -CH; Y is -S-, -CHCH-, or -HC═CH-; m is 0, 1, 2, or 3; and n is 0 or 1; or a phar...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: Dodge, Jeffrey Alan, Hughes, Norman Earle
Format: Patent
Sprache:eng
Online-Zugang:Volltext bestellen
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page
container_issue
container_start_page
container_title
container_volume
creator Dodge, Jeffrey Alan
Hughes, Norman Earle
description 14 1 14 214 21 22 322 The present invention provides a compound of the formula (I) wherein R is -H, or -C-Calkyl; Ris -H, -OH, -O(C-Calkyl), -SO(C-Calkyl), or halo; X is -O-, -CH-, or -C(O)-; Xis -O- or -NR-; Ris -H or -CH; Y is -S-, -CHCH-, or -HC═CH-; m is 0, 1, 2, or 3; and n is 0 or 1; or a pharmaceutically acceptable salt thereof; pharmaceutical compositions thereof; and methods for inhibiting a disease associated with an aberrant physiological response to endogenous estrogen.
format Patent
fullrecord <record><control><sourceid>uspatents_EFH</sourceid><recordid>TN_cdi_uspatents_grants_07462647</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>07462647</sourcerecordid><originalsourceid>FETCH-uspatents_grants_074626473</originalsourceid><addsrcrecordid>eNqNizEKAkEMRaexEPUOcwFBdNk9gCiWW9hLcDK7YkyGJFN4e0fwAFYP3n9_GcYR2YEyVVEBegKjVcoPflNkKLPPQNhcBE5RkcAxRTRXmZCbuGNx0fiSVNsmauuwyECGmx9XIZ5P1-NlW620M7vdJoUvdkPX7_tuOPyRfAAznDnu</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>Pentalfluoroalkanesulfinyl naphthalenes and related estrogen receptor modulators</title><source>USPTO Issued Patents</source><creator>Dodge, Jeffrey Alan ; Hughes, Norman Earle</creator><creatorcontrib>Dodge, Jeffrey Alan ; Hughes, Norman Earle ; Eli Lilly and Company</creatorcontrib><description>14 1 14 214 21 22 322 The present invention provides a compound of the formula (I) wherein R is -H, or -C-Calkyl; Ris -H, -OH, -O(C-Calkyl), -SO(C-Calkyl), or halo; X is -O-, -CH-, or -C(O)-; Xis -O- or -NR-; Ris -H or -CH; Y is -S-, -CHCH-, or -HC═CH-; m is 0, 1, 2, or 3; and n is 0 or 1; or a pharmaceutically acceptable salt thereof; pharmaceutical compositions thereof; and methods for inhibiting a disease associated with an aberrant physiological response to endogenous estrogen.</description><language>eng</language><creationdate>2008</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://image-ppubs.uspto.gov/dirsearch-public/print/downloadPdf/7462647$$EPDF$$P50$$Guspatents$$Hfree_for_read</linktopdf><link.rule.ids>230,308,780,802,885,64039</link.rule.ids><linktorsrc>$$Uhttps://image-ppubs.uspto.gov/dirsearch-public/print/downloadPdf/7462647$$EView_record_in_USPTO$$FView_record_in_$$GUSPTO$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>Dodge, Jeffrey Alan</creatorcontrib><creatorcontrib>Hughes, Norman Earle</creatorcontrib><creatorcontrib>Eli Lilly and Company</creatorcontrib><title>Pentalfluoroalkanesulfinyl naphthalenes and related estrogen receptor modulators</title><description>14 1 14 214 21 22 322 The present invention provides a compound of the formula (I) wherein R is -H, or -C-Calkyl; Ris -H, -OH, -O(C-Calkyl), -SO(C-Calkyl), or halo; X is -O-, -CH-, or -C(O)-; Xis -O- or -NR-; Ris -H or -CH; Y is -S-, -CHCH-, or -HC═CH-; m is 0, 1, 2, or 3; and n is 0 or 1; or a pharmaceutically acceptable salt thereof; pharmaceutical compositions thereof; and methods for inhibiting a disease associated with an aberrant physiological response to endogenous estrogen.</description><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2008</creationdate><recordtype>patent</recordtype><sourceid>EFH</sourceid><recordid>eNqNizEKAkEMRaexEPUOcwFBdNk9gCiWW9hLcDK7YkyGJFN4e0fwAFYP3n9_GcYR2YEyVVEBegKjVcoPflNkKLPPQNhcBE5RkcAxRTRXmZCbuGNx0fiSVNsmauuwyECGmx9XIZ5P1-NlW620M7vdJoUvdkPX7_tuOPyRfAAznDnu</recordid><startdate>20081209</startdate><enddate>20081209</enddate><creator>Dodge, Jeffrey Alan</creator><creator>Hughes, Norman Earle</creator><scope>EFH</scope></search><sort><creationdate>20081209</creationdate><title>Pentalfluoroalkanesulfinyl naphthalenes and related estrogen receptor modulators</title><author>Dodge, Jeffrey Alan ; Hughes, Norman Earle</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-uspatents_grants_074626473</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>eng</language><creationdate>2008</creationdate><toplevel>online_resources</toplevel><creatorcontrib>Dodge, Jeffrey Alan</creatorcontrib><creatorcontrib>Hughes, Norman Earle</creatorcontrib><creatorcontrib>Eli Lilly and Company</creatorcontrib><collection>USPTO Issued Patents</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>Dodge, Jeffrey Alan</au><au>Hughes, Norman Earle</au><aucorp>Eli Lilly and Company</aucorp><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>Pentalfluoroalkanesulfinyl naphthalenes and related estrogen receptor modulators</title><date>2008-12-09</date><risdate>2008</risdate><abstract>14 1 14 214 21 22 322 The present invention provides a compound of the formula (I) wherein R is -H, or -C-Calkyl; Ris -H, -OH, -O(C-Calkyl), -SO(C-Calkyl), or halo; X is -O-, -CH-, or -C(O)-; Xis -O- or -NR-; Ris -H or -CH; Y is -S-, -CHCH-, or -HC═CH-; m is 0, 1, 2, or 3; and n is 0 or 1; or a pharmaceutically acceptable salt thereof; pharmaceutical compositions thereof; and methods for inhibiting a disease associated with an aberrant physiological response to endogenous estrogen.</abstract><oa>free_for_read</oa></addata></record>
fulltext fulltext_linktorsrc
identifier
ispartof
issn
language eng
recordid cdi_uspatents_grants_07462647
source USPTO Issued Patents
title Pentalfluoroalkanesulfinyl naphthalenes and related estrogen receptor modulators
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-20T13%3A45%3A37IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-uspatents_EFH&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=Dodge,%20Jeffrey%20Alan&rft.aucorp=Eli%20Lilly%20and%20Company&rft.date=2008-12-09&rft_id=info:doi/&rft_dat=%3Cuspatents_EFH%3E07462647%3C/uspatents_EFH%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true